Dr. Yvanka Gilliam has over 23 years of clinical operations, medical affairs, health economics outcomes research (HEOR), Business Development, and Market access experience focusing on Emerging markets within the Pharmaceutical, Biotechnology, and Diagnostic industries.
She is the CEO and Founder of Clinical Research Advancement, Inc. based in the US and Clinical Research Advancement Pte. Ltd. based in Singapore.
Yvanka is currently the Chief Clinical Officer for Reveles, Inc. and the Head of Clinical Alliances for Singapore Clinical Research Institute (SCRI).
Yvanka has served as the Vice President of Operations for Diaceutics within the Asia Pacific, Middle East & Africa regions. Before joining Diaceutics, she was the VP of Clinical Affairs and Real World Evidence (RWE) with Kantar Health. She has also served as the VP, Head of Real World Evidence at IQVIA Singapore.